Revolutionary Breakthroughs: How Krystal Biotech is Tackling Rare Skin Diseases with Cutting-Edge Gene Therapy
Krystal Biotech is pioneering treatments for rare skin disorders using an HSV-1-based gene therapy platform. The company's vectors, including KB111 and KB112, effectively target skin keratinocytes with minimal toxicity. Significant…